 | • レポートコード：B-GIR08C0306 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、抗AIDS薬の世界市場について調べ、まとめました。種類別セグメントは、処方薬、非処方薬等、用途別セグメントは、薬局、病院等に区分しました。抗AIDS薬の世界市場概観、企業動向、企業別抗AIDS薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗AIDS薬の市場概観 ・抗AIDS薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗AIDS薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗AIDS薬の世界市場規模 ・抗AIDS薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗AIDS薬のアメリカ市場規模推移 ・抗AIDS薬のカナダ市場規模推移 ・抗AIDS薬のメキシコ市場規模推移 ・抗AIDS薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・抗AIDS薬のドイツ市場規模推移 ・抗AIDS薬のイギリス市場規模推移 ・抗AIDS薬のロシア市場規模推移 ・抗AIDS薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・抗AIDS薬の日本市場規模推移 ・抗AIDS薬の中国市場規模推移 ・抗AIDS薬の韓国市場規模推移 ・抗AIDS薬のインド市場規模推移 ・抗AIDS薬の東南アジア市場規模推移 ・抗AIDS薬の南米市場分析（ブラジル、アルゼンチン等） ・抗AIDS薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・抗AIDS薬の種類別分析/販売量、売上、市場シェア（処方薬、非処方薬） ・抗AIDS薬の用途別分析/市場規模（薬局、病院） ・抗AIDS薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・抗AIDS薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Anti-AIDs Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anti-AIDs Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GSK
Cipla
MSD
Gilead Sciences
Frontier Biotechnologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription Drugs
Non-prescription Drugs
Market Segment by Applications, can be divided into
Pharmacy
Hospital
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-AIDs Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-AIDs Drug, with price, sales, revenue and global market share of Anti-AIDs Drug in 2017 and 2018.
Chapter 3, the Anti-AIDs Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-AIDs Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anti-AIDs Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anti-AIDs Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-AIDs Drug Introduction
1.2 Market Analysis by Type
1.2.1 Prescription Drugs
1.2.2 Non-prescription Drugs
1.3 Market Analysis by Applications
1.3.1 Pharmacy
1.3.2 Hospital
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Anti-AIDs Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cipla
2.2.1 Business Overview
2.2.2 Anti-AIDs Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cipla Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 MSD
2.3.1 Business Overview
2.3.2 Anti-AIDs Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Gilead Sciences
2.4.1 Business Overview
2.4.2 Anti-AIDs Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Gilead Sciences Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Frontier Biotechnologies
2.5.1 Business Overview
2.5.2 Anti-AIDs Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Frontier Biotechnologies Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anti-AIDs Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anti-AIDs Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anti-AIDs Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-AIDs Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Anti-AIDs Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anti-AIDs Drug Market Analysis by Regions
4.1 Global Anti-AIDs Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-AIDs Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anti-AIDs Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Anti-AIDs Drug Sales and Growth Rate (2014-2019)
4.3 Europe Anti-AIDs Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anti-AIDs Drug Sales and Growth Rate (2014-2019)
4.5 South America Anti-AIDs Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anti-AIDs Drug Sales and Growth Rate (2014-2019)
5 North America Anti-AIDs Drug by Country
5.1 North America Anti-AIDs Drug Sales, Revenue and Market Share by Country
5.1.1 North America Anti-AIDs Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Anti-AIDs Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Anti-AIDs Drug Sales and Growth Rate (2014-2019)
5.3 Canada Anti-AIDs Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Anti-AIDs Drug Sales and Growth Rate (2014-2019)
6 Europe Anti-AIDs Drug by Country
6.1 Europe Anti-AIDs Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-AIDs Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anti-AIDs Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Anti-AIDs Drug Sales and Growth Rate (2014-2019)
6.3 UK Anti-AIDs Drug Sales and Growth Rate (2014-2019)
6.4 France Anti-AIDs Drug Sales and Growth Rate (2014-2019)
6.5 Russia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
6.6 Italy Anti-AIDs Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anti-AIDs Drug by Country
7.1 Asia-Pacific Anti-AIDs Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anti-AIDs Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anti-AIDs Drug Revenue and Market Share by Country (2014-2019)
7.2 China Anti-AIDs Drug Sales and Growth Rate (2014-2019)
7.3 Japan Anti-AIDs Drug Sales and Growth Rate (2014-2019)
7.4 Korea Anti-AIDs Drug Sales and Growth Rate (2014-2019)
7.5 India Anti-AIDs Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
8 South America Anti-AIDs Drug by Country
8.1 South America Anti-AIDs Drug Sales, Revenue and Market Share by Country
8.1.1 South America Anti-AIDs Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Anti-AIDs Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anti-AIDs Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Anti-AIDs Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anti-AIDs Drug by Countries
9.1 Middle East and Africa Anti-AIDs Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anti-AIDs Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anti-AIDs Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Anti-AIDs Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Anti-AIDs Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Anti-AIDs Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Anti-AIDs Drug Sales and Growth Rate (2014-2019)
10 Global Anti-AIDs Drug Market Segment by Type
10.1 Global Anti-AIDs Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anti-AIDs Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Anti-AIDs Drug Revenue and Market Share by Type (2014-2019)
10.2 Prescription Drugs Sales Growth and Price
10.2.1 Global Prescription Drugs Sales Growth (2014-2019)
10.2.2 Global Prescription Drugs Price (2014-2019)
10.3 Non-prescription Drugs Sales Growth and Price
10.3.1 Global Non-prescription Drugs Sales Growth (2014-2019)
10.3.2 Global Non-prescription Drugs Price (2014-2019)
11 Global Anti-AIDs Drug Market Segment by Application
11.1 Global Anti-AIDs Drug Sales Market Share by Application (2014-2019)
11.2 Pharmacy Sales Growth (2014-2019)
11.3 Hospital Sales Growth (2014-2019)
12 Anti-AIDs Drug Market Forecast (2019-2024)
12.1 Global Anti-AIDs Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Anti-AIDs Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Anti-AIDs Drug Market Forecast (2019-2024)
12.2.2 Europe Anti-AIDs Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anti-AIDs Drug Market Forecast (2019-2024)
12.2.4 South America Anti-AIDs Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anti-AIDs Drug Market Forecast (2019-2024)
12.3 Anti-AIDs Drug Market Forecast by Type (2019-2024)
12.3.1 Global Anti-AIDs Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Anti-AIDs Drug Market Share Forecast by Type (2019-2024)
12.4 Anti-AIDs Drug Market Forecast by Application (2019-2024)
12.4.1 Global Anti-AIDs Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Anti-AIDs Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Anti-AIDs Drug Picture
Table Product Specifications of Anti-AIDs Drug
Figure Global Sales Market Share of Anti-AIDs Drug by Types in 2018
Table Anti-AIDs Drug Types for Major Manufacturers
Figure Prescription Drugs Picture
Figure Non-prescription Drugs Picture
Figure Anti-AIDs Drug Sales Market Share by Applications in 2018
Figure Pharmacy Picture
Figure Hospital Picture
Figure United States Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Anti-AIDs Drug Revenue (Value) and Growth Rate (2014-2024)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Anti-AIDs Drug Type and Applications
Table GSK Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Anti-AIDs Drug Type and Applications
Table Cipla Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Anti-AIDs Drug Type and Applications
Table MSD Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Anti-AIDs Drug Type and Applications
Table Gilead Sciences Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Frontier Biotechnologies Basic Information, Manufacturing Base and Competitors
Table Frontier Biotechnologies Anti-AIDs Drug Type and Applications
Table Frontier Biotechnologies Anti-AIDs Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anti-AIDs Drug Sales by Manufacturer (2017-2018)
Figure Global Anti-AIDs Drug Sales Market Share by Manufacturer in 2017
Figure Global Anti-AIDs Drug Sales Market Share by Manufacturer in 2018
Table Global Anti-AIDs Drug Revenue by Manufacturer (2017-2018)
Figure Global Anti-AIDs Drug Revenue Market Share by Manufacturer in 2017
Figure Global Anti-AIDs Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Anti-AIDs Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Anti-AIDs Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Global Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table Global Anti-AIDs Drug Sales by Regions (2014-2019)
Table Global Anti-AIDs Drug Sales Market Share by Regions (2014-2019)
Table Global Anti-AIDs Drug Revenue by Regions (2014-2019)
Figure Global Anti-AIDs Drug Revenue Market Share by Regions in 2014
Figure Global Anti-AIDs Drug Revenue Market Share by Regions in 2018
Figure North America Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Europe Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure South America Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure North America Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table North America Anti-AIDs Drug Sales by Countries (2014-2019)
Table North America Anti-AIDs Drug Sales Market Share by Countries (2014-2019)
Figure North America Anti-AIDs Drug Sales Market Share by Countries in 2014
Figure North America Anti-AIDs Drug Sales Market Share by Countries in 2018
Table North America Anti-AIDs Drug Revenue by Countries (2014-2019)
Table North America Anti-AIDs Drug Revenue Market Share by Countries (2014-2019)
Figure North America Anti-AIDs Drug Revenue Market Share by Countries in 2014
Figure North America Anti-AIDs Drug Revenue Market Share by Countries in 2018
Figure United States Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Canada Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Mexico Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Europe Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table Europe Anti-AIDs Drug Sales by Countries (2014-2019)
Table Europe Anti-AIDs Drug Sales Market Share by Countries (2014-2019)
Table Europe Anti-AIDs Drug Revenue by Countries (2014-2019)
Figure Europe Anti-AIDs Drug Revenue Market Share by Countries in 2017
Figure Europe Anti-AIDs Drug Revenue Market Share by Countries in 2018
Figure Germany Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure UK Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure France Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Russia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Italy Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anti-AIDs Drug Sales by Countries (2014-2019)
Table Asia-Pacific Anti-AIDs Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Anti-AIDs Drug Sales Market Share by Countries 2018
Table Asia-Pacific Anti-AIDs Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Anti-AIDs Drug Revenue Market Share by Countries 2018
Figure China Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Japan Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Korea Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure India Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure South America Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table South America Anti-AIDs Drug Sales by Countries (2014-2019)
Table South America Anti-AIDs Drug Sales Market Share by Countries (2014-2019)
Figure South America Anti-AIDs Drug Sales Market Share by Countries in 2018
Table South America Anti-AIDs Drug Revenue by Countries (2014-2019)
Table South America Anti-AIDs Drug Revenue Market Share by Countries (2014-2019)
Figure South America Anti-AIDs Drug Revenue Market Share by Countries in 2018
Figure Brazil Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Argentina Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Colombia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anti-AIDs Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anti-AIDs Drug Sales by Countries (2014-2019)
Table Middle East and Africa Anti-AIDs Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-AIDs Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Anti-AIDs Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Anti-AIDs Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anti-AIDs Drug Revenue Market Share by Countries in 2014
Figure Middle East and Africa Anti-AIDs Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure UAE Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Egypt Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Figure South Africa Anti-AIDs Drug Sales and Growth Rate (2014-2019)
Table Global Anti-AIDs Drug Sales by Type (2014-2019)
Table Global Anti-AIDs Drug Sales Share by Type (2014-2019)
Table Global Anti-AIDs Drug Revenue by Type (2014-2019)
Table Global Anti-AIDs Drug Revenue Share by Type (2014-2019)
Figure Global Prescription Drugs Sales Growth (2014-2019)
Figure Global Prescription Drugs Price (2014-2019)
Figure Global Non-prescription Drugs Sales Growth (2014-2019)
Figure Global Non-prescription Drugs Price (2014-2019)
Table Global Anti-AIDs Drug Sales by Application (2014-2019)
Table Global Anti-AIDs Drug Sales Share by Application (2014-2019)
Figure Global Hospital Sales Growth (2014-2019)
Figure Global Anti-AIDs Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Anti-AIDs Drug Sales Forecast by Regions (2019-2024)
Table Global Anti-AIDs Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Anti-AIDs Drug Market Forecast (2019-2024)
Figure Europe Sales Anti-AIDs Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Anti-AIDs Drug Market Forecast (2019-2024)
Figure South America Sales Anti-AIDs Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Anti-AIDs Drug Market Forecast (2019-2024)
Table Global Anti-AIDs Drug Sales Forecast by Type (2019-2024)
Table Global Anti-AIDs Drug Market Share Forecast by Type (2019-2024)
Table Global Anti-AIDs Drug Sales Forecast by Application (2019-2024)
Table Global Anti-AIDs Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
抗肥満処方薬市場：世界及び中国市場分析・予測（～2024年） Anti-Obesity Prescription Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Anti-Obesity Prescription Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Anti-O…- 世界の処方呼吸器薬市場2019 A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. The global Prescription Respiratory Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report st…
- 睡眠薬（処方薬）の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Sleeping Pills (Prescription Drugs) is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Sleeping Pill…
- 非処方老眼鏡の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Non-prescription Reading Glasses is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Non-pr…
- 急性片頭痛薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Acute medications fall into general classes of medicines including analgesics, ergotamines and triptans. Scope of the Report: The worldwide market for Acute Migraine Drugs is expected to grow at a CAGR…